Holbrook Kerr 4
4 · AVANOS MEDICAL, INC. · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2023-03-06+24,233→ 57,097 total - Tax Payment
Common Stock
2023-03-06$29.62/sh−1,513$44,815→ 55,584 total
Footnotes (3)
- [F1]Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
- [F2]Total beneficially owned includes 249 shares acquired on December 30, 2022 and 510 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.